Search research articles
Contact Us
Filters
Showing results (11-20 of 616) with videos related to
Page
of 62
Sort By:
Clinical and Molecular Hepatology
|
September 18, 2023
From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
Ming-Lun Yeh, Ming-Lung Yu
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
September 10, 2025
Response to the Letter to the Editor Regarding "Assessing the link between post-treatment ALT and HCC risk in chronic hepatitis C"
Yen-Chun Chen, Ming-Lung Yu
Journal of Hepatology
|
April 25, 2020
Reply to "DAA and HBV/HCV co-infection: Glimmer of light and a few shades of grey"
Ming-Lun Yeh, Ming-Lung Yu
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
June 22, 2025
Reply to the comment on "High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C"
Yen-Chun Chen, Ming-Lung Yu
Journal of Gastroenterology
|
October 30, 2012
Host factors determining the efficacy of hepatitis C treatment
Wan-Long Chuang, Ming-Lung Yu
Clinical and Molecular Hepatology
|
April 11, 2024
Reply to correspondence on "Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide"
Pin-Nan Cheng, Ming-Lung Yu
The Kaohsiung Journal of Medical Sciences
|
December 18, 2020
Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020
Ming-Lung Yu, Wan-Long Chuang
Hepatitis Research and Treatment
|
December 15, 2010
Evolution of interferon-based therapy for chronic hepatitis C
Chun-Hao Chen, Ming-Lung Yu
Expert Opinion on Pharmacotherapy
|
November 1, 2017
Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments
Chung-Feng Huang, Ming-Lung Yu
Kidney International
|
February 24, 2020
Daclatasvir plus asunaprevir in the treatment of uremic patients with chronic hepatitis C genotype 1b infection
Chung-Feng Huang, Ming-Lung Yu
Page
of 62
Search research articles
Search
Showing results (11-20 of 616) with videos related to
Sort By:
Page
of 62
Clinical and Molecular Hepatology
|
September 18, 2023
From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
Ming-Lun Yeh, Ming-Lung Yu
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
September 10, 2025
Response to the Letter to the Editor Regarding "Assessing the link between post-treatment ALT and HCC risk in chronic hepatitis C"
Yen-Chun Chen, Ming-Lung Yu
Journal of Hepatology
|
April 25, 2020
Reply to "DAA and HBV/HCV co-infection: Glimmer of light and a few shades of grey"
Ming-Lun Yeh, Ming-Lung Yu
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
June 22, 2025
Reply to the comment on "High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C"
Yen-Chun Chen, Ming-Lung Yu
Journal of Gastroenterology
|
October 30, 2012
Host factors determining the efficacy of hepatitis C treatment
Wan-Long Chuang, Ming-Lung Yu
Clinical and Molecular Hepatology
|
April 11, 2024
Reply to correspondence on "Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide"
Pin-Nan Cheng, Ming-Lung Yu
The Kaohsiung Journal of Medical Sciences
|
December 18, 2020
Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020
Ming-Lung Yu, Wan-Long Chuang
Hepatitis Research and Treatment
|
December 15, 2010
Evolution of interferon-based therapy for chronic hepatitis C
Chun-Hao Chen, Ming-Lung Yu
Expert Opinion on Pharmacotherapy
|
November 1, 2017
Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments
Chung-Feng Huang, Ming-Lung Yu
Kidney International
|
February 24, 2020
Daclatasvir plus asunaprevir in the treatment of uremic patients with chronic hepatitis C genotype 1b infection
Chung-Feng Huang, Ming-Lung Yu
Page
of 62